Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 16;23(6):3197.
doi: 10.3390/ijms23063197.

Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends

Affiliations
Review

Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends

Ana C Gonçalves et al. Int J Mol Sci. .

Abstract

Plant-derived products and their extracted compounds have been used in folk medicine since early times. Zimbro or common juniper (Juniperus communis) is traditionally used to treat renal suppression, acute and chronic cystitis, bladder catarrh, albuminuria, leucorrhea, and amenorrhea. These uses are mainly attributed to its bioactive composition, which is very rich in phenolics, terpenoids, organic acids, alkaloids, and volatile compounds. In the last few years, several studies have analyzed the huge potential of this evergreen shrub, describing a wide range of activities with relevance in different biomedical discipline areas, namely antimicrobial potential against human pathogens and foodborne microorganisms, notorious antioxidant and anti-inflammatory activities, antidiabetic, antihypercholesterolemic and antihyperlipidemic effects, and neuroprotective action, as well as antiproliferative ability against cancer cells and the ability to activate inductive hepato-, renal- and gastroprotective mechanisms. Owing to these promising activities, extracts and bioactive compounds of juniper could be useful for the development of new pharmacological applications in the treatment of several acute and chronic human diseases.

Keywords: Juniperus communis L.; bioactive compounds; biological potential; essential oils; in vitro studies; in vivo studies; phenolic compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Juniperus communis (A) main view of the plant growing in Serra da Estrela, (B) detail of leaves, and (C) details of berries. Images under Creative Commons licence, authorship: João Domingues Almeida and Paulo Ventura Araújo from www.flora-on.pt, accessed on 10 March 2022.
Figure 2
Figure 2
Main phytochemicals found in Juniperus communis L. (adapted from Fátima et al. [55]).
Figure 3
Figure 3
Main phenolic compounds found in Juniperus communis L. vegetal parts.
Figure 4
Figure 4
The main volatile organic compound found in Juniperus communis L. parts.
Figure 5
Figure 5
Main health-promoting properties attributed to Juniperus communis L. AST: aspartate aminotransferase; ALT: alanine aminotransferase; AChE: acetylcholinesterase; BChE): butyrylcholinesterase; Bax: Bcl-2-associated X protein; AIF: apoptosis-inducing factor; Fas: cell-surface death receptor; FasL: Fas ligand; Bcl-2: B-cell lymphoma 2; ↑: increase; ↓: reduction; T: inhibition.

Similar articles

Cited by

References

    1. Gezici S., Şekeroğlu N. Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents. Anticancer Agents Med. Chem. 2019;19:101–111. doi: 10.2174/1871520619666181224121004. - DOI - PubMed
    1. Benarba B., Pandiella A. Colorectal cancer and medicinal plants: Principle findings from recent studies. Biomed. Pharmacother. 2018;107:408–423. doi: 10.1016/j.biopha.2018.08.006. - DOI - PubMed
    1. Sen T., Samanta S.K. Advances in Biochemical Engineering/Biotechnology. Volume 147. Springer; Berlin/Heidelberg, Germany: 2015. Medicinal plants, human health and biodiversity: A broad review; pp. 59–110. - PubMed
    1. Dutra R.C., Campos M.M., Santos A.R.S., Calixto J.B. Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives. Pharmacol. Res. 2016;112:4–29. doi: 10.1016/j.phrs.2016.01.021. - DOI - PubMed
    1. Gholipour S., Sewell R.D.E., Lorigooini Z., Rafieian-Kopaei M. Medicinal plants and atherosclerosis: A review on molecular aspects. Curr. Pharm. Des. 2018;24:3123–3131. doi: 10.2174/1381612824666180911121525. - DOI - PubMed

LinkOut - more resources